Skip to main content
. 2014 Jan 29;111(8):1574–1589. doi: 10.1152/jn.00668.2013

Table 1.

Percentage of VTT neurons tested with and responding to a specific number of pruritogens and/or partial pruritogens injected intradermally in the face

No. of Pruritogens Tested No. of Pruritogens Eliciting a Response
0 1 2 3 4 5
≥1 (N = 104) 52% (n = 54) 31% (n = 32) 10% (n = 10) 6% (n = 6) 2% (n = 2) 0% (n = 0)
≥2 (N = 92) 58% (n = 53) 23% (n = 21) 11% (n = 10) 6% (n = 6) 2% (n = 2) 0% (n = 0)
≥3 (N = 87) 60% (n = 52) 20% (n = 17) 11% (n = 10) 7% (n = 6) 2% (n = 2) 0% (n = 0)
≥4 (N = 62) 50% (n = 31) 21% (n = 13) 16% (n = 10) 10% (n = 6) 3% (n = 2) 0% (n = 0)
≥5 (N = 47) 45% (n = 21) 19% (n = 9) 21% (n = 10) 11% (n = 5) 4% (n = 2) 0% (n = 0)

Percentages are calculated by dividing the number of neurons in which a specific number of pruritogens and/or partial pruritogens elicited a response (n) by the total number of neurons in which a specific number of pruritogens and/or partial pruritogens was tested (N). For example, in the 3rd column “23%” refers to the number of neurons in which 1 pruritogen elicited a response (n = 21) divided by the number of neurons in which ≥2 pruritogens were tested (N = 92). Data include neurons tested with the pruritogens serotonin, BAM8-22, chloroquine, cowhage, and/or the partial pruritogens histamine and capsaicin. VTT, trigeminothalamic tract.